Specialty chemicals company Sudarshan Pharma has informed exchanges that it has acquired 209100 equity shares of Ishwari Healthcare of Rs 10 each (51 per cent of paid up equity share capital) at a revised consideration of Rs 15000000. The equity shares were acquired at Rs 71.73 apiece. Consequent to the acquisition Ishwari Healthcare has become a subsidiary of Sudarshan Pharma from April 1 2025. Meanwhile shares of Sudarshan Pharma Industries which is engaged in specialty chemicals and intermediates for pharma agro chemicals paints adhesive and various other industries ended the session in the red. The counter started the session at Rs 31.36 on the BSE against the previous close of Rs 31.99. It fell further to touch the low of Rs 31.36. The 52-week high of the stock is Rs 53.50 and the 52-week high is Rs 5.82. Meanwhile benchmark equity indices Sensex and Nifty slumped in initial trade on Friday due to heavy selling in metal oil & gas shares as President Donald Trumps sweeping tariff salvo reignited the fears of global trade war. Besides foreign fund outflows have also dented the investor sentiment. The 30-share BSE Sensex slumped 591.05 points or 0.77 per cent to 75704.31 in the morning trade. The broader NSE Nifty declined 202.55 points or 0.87 per cent to 23047.55. From the Sensex pack Tata Motors Tata Steel Larsen & Toubro Reliance Industries Maruti Suzuki India IndusInd Bank Infosys HCL Technologies NTPC Tech Mahindra Sun Pharmaceutical Industries and Adani Ports were among the laggards. In contrast HDFC Bank Bajaj Finance Bharti Airtel Mahindra & Mahindra Kotak Mahindra Bank ICICI Bank Nestle India and Hindustan Unilever were the gainers. Trump on Wednesday announced a 27 per cent discounted reciprocal tariff on India half of the 52 per cent levies imposed by India on American goods as he described India as very very tough.